Skip to main content

Table 1 Laboratory and demographic data of cases and controls

From: Circulating microRNAs as predictors of response to sofosbuvir + daclatasvir + ribavirin in in HCV genotype-4 Egyptian patients

 

Controls

N = 50

Patients

N = 150

p value

Mean ± SD

Mean ± SD

Age

45.2 ± 6.9

48.0 ± 7.6

0.061

Sex

   

 Males

27 (54%)

72 (48%)

0.462

 Females

23 (46%)

78 (52%)

ALT (U/L)

24.4 ± 2.7

56.0 ± 4.3

< 0.001*

AST (U/L)

21.4 ± 3.1

54.2 ± 4.2

< 0.001*

Albumin (g/Dl)

4.7 ± 0.3

3.9 ± 0.9

< 0.001*

PT

98.4 ± 1.4

89.9 ± 1.8

< 0.001*

  1. *Difference is statistically significant (p < 0.05)